CG Oncology Quarterly Balance Sheet
NASDAQ: CGONHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CG Oncology financial position
As of Jun 30, 2026, CG Oncology reported total assets of $1.09 billion, up 54.8% from a year earlier against total liabilities of $56.5 million. Shareholders' equity stood at $1.03 billion, or 94.8% of assets. The company held $19.6 million in cash and equivalents against $3.0 million of debt, a net cash position of $16.6 million.
The current ratio (current assets divided by current liabilities) was 22.22, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.00.
Summary generated from market data by MetaCap's automated system. Methodology
CG Oncology balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 19.64M | 33.70M | 32.49M | 45.15M | 14.62M | 41.47M | 257.07M | 43.41M | 25.16M | 77.47M | 8.27M | 10.27M |
| Short-Term Investments | 1.01B | 1.04B | 709.66M | 635.12M | 646.43M | 646.96M | 484.93M | 497.30M | 527.72M | 489.04M | 179.41M | — |
| Receivables | 417.00K | 1.27M | 688.00K | 515.00K | — | — | 0 | — | — | — | — | — |
| Inventory | 1.00M | 1.49M | 1.56M | 1.50M | — | — | 0 | — | — | — | — | — |
| Total Current Assets | 1.05B | 1.10B | 759.48M | 695.79M | 673.03M | 701.19M | 754.21M | 552.08M | 563.86M | 578.61M | 194.12M | — |
| Property, Plant & Equipment | 14.71M | 15.07M | 15.60M | 15.33M | 253.00K | 264.00K | 272.00K | 63.00K | 84.00K | 77.00K | 69.00K | — |
| Goodwill | 10.30M | 10.30M | 10.30M | 12.80M | — | — | 0 | — | — | — | — | — |
| Intangible Assets | 545.00K | 560.00K | 575.00K | 1.67M | — | — | 0 | — | — | — | — | — |
| Total Assets | 1.09B | 1.14B | 791.59M | 729.91M | 701.45M | 728.18M | 754.80M | 552.47M | 564.33M | 579.11M | 199.30M | — |
| Accounts Payable | 12.73M | 8.24M | 5.71M | 9.19M | 7.13M | 6.73M | 6.52M | 4.08M | 4.49M | 4.66M | 3.24M | — |
| Total Current Liabilities | 47.24M | 35.22M | 30.84M | 30.53M | 30.38M | 22.64M | 21.37M | 15.63M | 11.85M | 9.98M | 14.25M | — |
| Long-Term Debt | 3.00M | 3.00M | 3.00M | 3.00M | — | — | 0 | — | — | — | — | — |
| Total Liabilities | 56.54M | 43.48M | 38.99M | 42.27M | 31.09M | 23.42M | 21.42M | 15.70M | 11.97M | 10.17M | 14.51M | — |
| Shareholders' Equity | 1.03B | 1.09B | 752.60M | 687.64M | 670.36M | 704.76M | 733.38M | 536.77M | 552.36M | 568.94M | -123.10M | -107.58M |
| Retained Earnings | -518.23M | -439.18M | -378.98M | -337.67M | -293.86M | -252.43M | -217.98M | -186.18M | -165.78M | -146.87M | -129.94M | — |
| Total Debt | 3.00M | 3.00M | 3.00M | 3.00M | — | — | 0 | — | — | — | — | — |
| Net Cash (Debt) | 1.03B | 1.07B | 739.15M | 677.26M | 661.05M | 688.43M | 742.00M | 540.71M | 552.88M | 566.51M | 187.67M | 10.27M |
| Shares Outstanding | 88.31M | 88.01M | 80.69M | 78.28M | 76.23M | 76.22M | 76.15M | 67.54M | 66.66M | 66.64M | 5.22M | — |
This table shows 12 quarterly periods of CG Oncology's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow CGON's reporting calendar. What is a balance sheet?